رجوع
نطاق اليوم
KWD 2.03
KWD 2.10
نطاق 52 أسبوعًا
KWD 1.77
KWD 5.81
حجم التداول
1,646,877
متوسط 50 يوم / 200 يوم
KWD 2.35
/
KWD 3.51
الإغلاق السابق
KWD 2.08
Quick Summary
تاريخ السعر
الاتجاهات المالية
مقارنة الأقران
مقابل وسيط قطاع Healthcare (627 نظير)
| المقياس | السهم | وسيط القطاع |
|---|---|---|
| P/E | 23.0 | 0.4 |
| P/B | 1.1 | 2.9 |
| ROE % | 4.5 | 3.9 |
| Net Margin % | 3.8 | 3.8 |
| Rev Growth 5Y % | 1.7 | 10.0 |
| D/E | 0.1 | 0.2 |
السعر المستهدف للمحللين
Hold
KWD 3.19
+56.4%
Low: KWD 2.75
High: KWD 4.00
مكرر الربحية المستقبلي
6.51
ربحية السهم المستقبلية
KWD 0.32
نمو ربحية السهم (تقدير)
+0.0%
الإيرادات المقدّرة
764.76M
تقديرات الأرباح
| الفترة | تقدير ربحية السهم | تقدير الإيرادات | المحللون |
|---|---|---|---|
| FY2030 |
KWD 0.00
KWD 0.00 – KWD 0.00
|
914.80M | 2 |
| FY2029 |
KWD 0.89
KWD 0.86 – KWD 0.91
|
925.63M | 4 |
| FY2028 |
KWD 0.45
KWD 0.12 – KWD 0.84
|
866.61M | 6 |
No quarterly estimates available
Dividend History
Yield
0.00%
Payout Ratio
N/A
Growth (3Y)
N/A
Growth (5Y)
N/A
No dividend history available.
النقاط الرئيسية
Revenue grew 1.68% annually over 5 years — modest growth
Earnings grew 85.72% over the past year
ROE of 4.54% is below average
Debt/Equity of 0.10 — conservative balance sheet
Generating 164.38M in free cash flow
PEG of 0.31 suggests growth is underpriced
النمو
Revenue Growth (5Y)
1.68%
Revenue (1Y)0.57%
Earnings (1Y)85.72%
FCF Growth (3Y)41.13%
الجودة
Return on Equity
4.54%
ROIC11.87%
Net Margin3.82%
Op. Margin13.42%
الأمان
Debt / Equity
0.10
Current Ratio2.61
Interest Coverage2.51
التقييم
P/E Ratio
22.97
Forward P/EN/A
P/B Ratio1.13
EV/EBITDA4.64
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 0.57% | Revenue Growth (3Y) | 3.06% |
| Earnings Growth (1Y) | 85.72% | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 1.68% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 796.85M | Net Income (TTM) | 30.44M |
| ROE | 4.54% | ROA | 2.17% |
| Gross Margin | 82.09% | Operating Margin | 13.42% |
| Net Margin | 3.82% | Free Cash Flow (TTM) | 164.38M |
| ROIC | 11.87% | FCF Growth (3Y) | 41.13% |
| Safety | |||
| Debt / Equity | 0.10 | Current Ratio | 2.61 |
| Interest Coverage | 2.51 | ||
| Dividends | |||
| Dividend Yield | 0.00% | Payout Ratio | N/A |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | 22.97 | Forward P/E | N/A |
| P/B Ratio | 1.13 | P/S Ratio | 0.88 |
| PEG Ratio | 0.31 | Forward PEG | N/A |
| EV/EBITDA | 4.64 | Fwd EV/EBITDA | N/A |
| Forward P/S | N/A | Fwd Earnings Yield | N/A |
| FCF Yield | 23.51% | ||
| Market Cap | 699.10M | Enterprise Value | 496.82M |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 796.85M | 792.32M | 750.27M | 766.55M | 745.42M |
| Net Income | 30.44M | 16.39M | -8.87M | -32.83M | -25.25M |
| EPS (Diluted) | 0.09 | 0.04 | -0.02 | -0.08 | -0.06 |
| Gross Profit | 654.13M | 744.11M | 683.34M | 701.48M | 698.71M |
| Operating Income | 106.97M | 65.85M | -27.01M | 1.74M | 13.41M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 1.40B | 1.39B | 1.59B | 1.60B | 1.61B |
| Total Liabilities | 787.80M | 663.41M | 826.84M | 789.80M | 775.95M |
| Shareholders' Equity | 616.26M | 724.66M | 761.96M | 814.83M | 831.68M |
| Total Debt | 59.54M | 543.39M | 711.07M | 717.02M | 702.33M |
| Cash & Equivalents | 261.82M | 448.35M | 672.30M | 757.17M | 941.11M |
| Current Assets | 643.10M | 659.26M | 872.79M | 919.69M | 1.09B |
| Current Liabilities | 246.00M | 123.90M | 122.56M | 76.32M | 81.11M |